Literature DB >> 12034327

A novel MCA occlusion model of photothrombotic ischemia with cyclic flow reductions: development of cerebral hemorrhage induced by heparin.

Bing-Qiao Zhao1, Yasuhiro Suzuki, Kazunao Kondo, Ken-ichi Kawano, Yasuhiko Ikeda, Kazuo Umemura.   

Abstract

Intracerebral hemorrhage is the major complication associated with antithrombotic and thrombolytic therapy. Despite efforts directed toward achieving hemorrhagic infarction, an ideal animal model of cerebral hemorrhage has not yet to be established. Using the photothrombotic technique in rabbits, we developed a model of cerebral hemorrhage by inducing cyclic flow reductions in the middle cerebral artery (MCA). Furthermore, the hemorrhage increased 4-fold after infusion of heparin at a dose prolonging activated partial thromboplastin time by about three times that of control animals. The photothrombotic occlusion of the MCA is based on a thrombosis induced by endothelial injury through singlet oxygen produced by Rose Bengal injection and green light irradiation (Acta Neuropathol. 72 (1987) 315; Acta Neuropathol. 72 (1987) 326; J. Pharmacol. Toxicol. Methods. 29 (1993) 165). Using a pulse Doppler flowmeter, spontaneous reperfusion of the MCA after the thrombotic occlusion following cyclic flow reductions was observed within 2 h in the majority of animals. This model is unusual with respect to the development of clinical stroke, because of the MCA cyclic flow reductions. Thus it is different from permanent or ischemia/reperfusion MCA occlusion in rodents and may be suitable for studying hemorrhagic risks associated with the use of antithrombotic agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034327     DOI: 10.1016/s1385-299x(01)00124-6

Source DB:  PubMed          Journal:  Brain Res Brain Res Protoc        ISSN: 1385-299X


  8 in total

1.  Three variations in rabbit angiographic stroke models.

Authors:  William C Culp; Sean D Woods; Aliza T Brown; John D Lowery; Leah J Hennings; Robert D Skinner; Michael J Borrelli; Paula K Roberson
Journal:  J Neurosci Methods       Date:  2012-11-08       Impact factor: 2.390

Review 2.  Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models.

Authors:  Steven L Bernstein; Mary A Johnson; Neil R Miller
Journal:  Prog Retin Eye Res       Date:  2011-03-02       Impact factor: 21.198

3.  Stroke location and brain function in an embolic rabbit stroke model.

Authors:  Aliza T Brown; Robert D Skinner; Rene Flores; Leah Hennings; Michael J Borrelli; John Lowery; William C Culp
Journal:  J Vasc Interv Radiol       Date:  2010-04-22       Impact factor: 3.464

4.  Dodecafluoropentane Improves Neurological Function Following Anterior Ischemic Stroke.

Authors:  M Christine Arthur; Aliza Brown; Kristen Carlson; John Lowery; Robert D Skinner; William C Culp
Journal:  Mol Neurobiol       Date:  2016-08-08       Impact factor: 5.590

5.  Rodent model of nonarteritic ischemic optic neuropathy and its electrophysiological evaluation.

Authors:  Hideki Chuman; Tomoyuki Maekubo; Takako Osako; Yu Kodama; Michitaka Ishiai; Nobuhisa Nao-I
Journal:  Jpn J Ophthalmol       Date:  2012-08-03       Impact factor: 2.447

6.  Development of a photochemical thrombosis investigation system to obtain a rabbit ischemic stroke model.

Authors:  Yoonhee Kim; Yoon Bum Lee; Seung Kuk Bae; Sung Suk Oh; Jong-Ryul Choi
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

7.  Heparin inhibits NF-kappaB activation and increases cell death in cerebral endothelial cells after oxygen-glucose deprivation.

Authors:  Jeong Ho Lee; Jinu Lee; Gi Ho Seo; Chul Hoon Kim; Young Soo Ahn
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 2.866

Review 8.  Translational Stroke Research Review: Using the Mouse to Model Human Futile Recanalization and Reperfusion Injury in Ischemic Brain Tissue.

Authors:  Emilia Conti; Benedetta Piccardi; Alessandro Sodero; Laura Tudisco; Ivano Lombardo; Enrico Fainardi; Patrizia Nencini; Cristina Sarti; Anna Letizia Allegra Mascaro; Marzia Baldereschi
Journal:  Cells       Date:  2021-11-25       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.